Avantor stock
Price history
+35.03% over the period1 year: from $10.99 (November 20, 2025) to $14.84 (November 20, 2026), +35.03%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | $14.84 |
| October 30, 2026 | $16.05 |
| September 30, 2026 | $15.05 |
| August 31, 2026 | $14.54 |
| July 31, 2026 | $13.78 |
| June 30, 2026 | $9.90 |
| May 29, 2026 | $9.12 |
| April 30, 2026 | $8.10 |
| March 31, 2026 | $7.84 |
| February 27, 2026 | $9.05 |
| January 30, 2026 | $10.92 |
| December 31, 2025 | $11.46 |
| November 28, 2025 | $11.73 |
| November 20, 2025 | $10.99 |
At a glance
The company
Supply mission-critical products and services including chemicals, lab equipment, and specialized support to biopharma, healthcare, advanced tech and materials industries globally
Latest results
Quarter to September 30, 2026 · EPS $0.22 (estimate $0.21)
TickerLandia's take on Avantor
- Cheaper than similar companies: trailing 12-month P/E 30 vs 34 (−12%) in a group of 9.
- Strong point: Market momentum (90/100 in its group). Weak point: Growth (22/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−14.96% from the 52-week high
Analysts · 15 analysts
Average target$17.35+16.89% vs. price
Buy 2 · Hold 12 · Sell 1
TickerLandia Fingerprint: Avantor
Compared with similar companies: very strong momentum.
Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 888 North American stocks.
Pricelow27
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 16.7 31 P/E (trailing 12 months) 29.7 38 EV/EBITDA 14.0 34 Price/book 1.72 13 Price/sales 1.52 19 Profitabilitylow22
How much it earns on revenue and capital.
Metric Value Position in group ROA 2.8% 28 Net margin 5.1% 22 ROE 5.9% 28 Gross margin 31.6% 10 Operating margin 8.0% 22 Earnings stabilitylow38
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 2.7% 57 Loss-making yearscounts in reverse: lower means more earnings stability 1 of 5 annual reports 18 Growthlow22
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +4.60% 34 Average revenue growth (3 years) −4.46% 10 Financial strengthlow28
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 1.89 51 Debt/equitycounts in reverse: lower means more financial strength 0.63 35 Interest coverage 2.63 15 Net debt/EBITDAcounts in reverse: lower means more financial strength 3.80 11 Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumvery strong90
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +15.15% 78 Relative strength (6 months) +102.57% 99 1-year return +35.03% 83 Distance from 200-day average +29.15% 98 Riskaverage56
How much the price swings.
Metric Value Position in group Beta (1 year) 0.84 59 Volatility (60 days) 30.2% 37 Maximum drawdown (12 months) 41.2% 73
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Avantor is cheaper than similar companies
Avantor's P/E (trailing 12 months): 29.7, −12% against the median of a group of 9 similar companies (33.8).
Compared with 9 similar companies
| Metric | Avantor | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 29.7 | Middle | |
| Forward P/E | 16.7 | Middle | |
| Operating margin | 8.0% | Middle | |
| ROE | 5.9% | Middle | |
| Debt/equity | 0.63 | Middle |
Grey band: the middle half of the group; tick: the median; dot: Avantor. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$1.7B
Latest quarter · Q3 2026
Net income
$203.4M
Latest quarter · Q3 2026
Quarterly net margin
12.0%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $10.06B
- P/E
- 29.7
- EPS
- $0.50
- Volume
- 12.25M
- Daily trading
- €128.72M
- Dividend yield
- 0.00%
How Avantor is changing
All resultsRevenue grew 0.5% a year on average over the last 5 years
Operating margin fell from 15.3% to 8.9%
Shares outstanding up 16.7% in 5 years
Returns
Avantor returns
$1,000 invested in Avantor 5 years ago, on November 22, 2021, would be worth $372 today: −62.84% in total, −17.98% per year. This is the price return only: dividends are excluded.
| Period | Avantor | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | −10.71% | −10.40% | $893 |
| 6 months | +88.32% | −7.03% | $1,883 |
| Year to date | +29.49% | +0.95% | $1,295 |
| 1 year | +35.03% | +5.68% | $1,350 |
| 3 years | −23.66% | +51.96% | $763 |
| 5 years | −62.84% | +47.57% | $372 |
Over the last 6 months it has done better than 98% of the stocks in the Healthcare sector.
Price only, without dividends. Calculate your investment
The chart in detail
Avantor: technical analysis
Avantor shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 66.3% below its all-time closing high ($44.01, September 24, 2021).
- Trend
- No clear trend
- RSI (14 sessions)
- 37
- Between 30 and 70
- vs 200-session average
- +29.15%
Active signals
Close below the low of the previous 20 sessions.
Support and resistance
Price areas where Avantor has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$16.02+7.95%2 touches, last on November 12, 2026
- Last price$14.84
- Support$14.60−1.65%2 touches, last on October 1, 2026
- Support$12.99−12.47%2 touches, last on August 6, 2026
- Support$11.41−23.13%2 touches, last on July 15, 2026
Volatility and risk
Over the last year it has moved roughly in line with the S&P 500.
- Beta (1 year) vs S&P 500
- 0.84
- Volatility (60 sessions, annualised)
- 30.2%
- Largest fall in the last year
- −41.19%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Avantor: seasonality
Average monthly price change over 8 years
Over the last 8 years, the strongest month for Avantor has been July: +10.82% on average, positive in 5 years out of 8. The weakest has been February: −8.62% on average, positive in 2 years out of 7. November, the current month, has been positive in 4 years out of 7 (+8.70% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.45% | +1.76% | 5 of 7 |
| February | −8.62% | −7.07% | 2 of 7 |
| March | −6.46% | −2.93% | 2 of 7 |
| April | +1.42% | −5.24% | 3 of 7 |
| May | +3.92% | +0.50% | 5 of 7 |
| June | +1.26% | +3.63% | 5 of 8 |
| July | +10.82% | +2.99% | 5 of 8 |
| August | +0.01% | +1.22% | 5 of 8 |
| September | −5.04% | −1.49% | 3 of 8 |
| October | −3.46% | −2.30% | 3 of 8 |
| November | +8.70% | +10.46% | 4 of 7 |
| December | +2.30% | +3.19% | 5 of 7 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Avantor and its competitors
Around half of the sales of this Radnor-based group are made in the United States, while the rest comes from customers in Europe, Asia, the Middle East, Africa and other parts of the Americas. The company supplies laboratory and production materials such as chemicals, reagents, silicone materials and single-use assemblies, along with filtration systems, freezers, incubators and analytical instruments. It also offers onsite lab and production services, procurement and sourcing, and scientific research support, including cleanroom monitoring and sanitization.
- Headquarters
- Radnor, United States
- Employees
- 13,500
- Founded
- 1904
- Chief executive
- Emmanuel Ligner
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| AvantorAVTR | $10.06B | 8.0% | 29.7 | +88.32% |
| RepligenRGEN | $10.89B | 8.1% | — | +46.60% |
| Align TechnologyALGN | $10.94B | 19.6% | 22.6 | −5.03% |
| Cooper CompaniesCOO | $11.2B | 12.9% | 20.2 | −4.65% |
| AptarGroupATR | $8.88B | 12.4% | 33.8 | +21.53% |
| Baxter InternationalBAX | $13.14B | 7.6% | — | +35.27% |
Same industry or related industries, similar size. Compare Avantor with its competitors · Full profile
